| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Acne Vulgaris | D000152 | 35 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Total
4
13-cis-retinoic acid,Isotretinoin
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
Cross Reference
Introduction
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 13-cis-retinoic acid,Isotretinoin?
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
PubChem Associated disorders and diseases
What pathways are associated with 13-cis-retinoic acid,Isotretinoin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
What genes are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 13-cis-retinoic acid,Isotretinoin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhu J et al. | [3 retinoic acid isomers on proliferation and differentiation properties of APL cell line-NB4]. | 1995 | Zhonghua Yi Xue Za Zhi | pmid:7780822 |
| Tang SQ et al. | [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid]. | 2004 | Zhonghua Er Ke Za Zhi | pmid:15324562 |
| Jiang XG and Xi NZ | [A reversed-phase HPLC method for determining tretinoin]. | 1994 | Zhongguo Yao Li Xue Bao | pmid:7717076 |
| Liu CZ et al. | [Randomized control study on the treatment of 26 cases of acne conglobata with encircling acupuncture combined with venesection and cupping]. | 2008 | Zhen Ci Yan Jiu | pmid:19288903 |
| Melnik B and Plewig G | [New lipid biochemical aspects in the pathogenesis of a follicular keratinization disorder in acne vulgaris]. | 1988 | Z. Hautkr. | pmid:2973184 |
| Mayerhausen W and Riebel B | [Acne fulminans following use of anabolic steroids]. | 1989 | Z. Hautkr. | pmid:2531507 |
| Park YK et al. | Pachydermoperiostosis: trial with isotretinoin. | 1988 | Yonsei Med. J. | pmid:3064439 |
| Lee SM et al. | A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug. | 2009 | Yonsei Med. J. | pmid:19568610 |
| Wang QF et al. | [The preparation and kinetic study on enzymatically-controlled drug release of isotretinoin/amylose inclusion complex]. | 2012 | Yao Xue Xue Bao | pmid:23227555 |
| Vane FM et al. | Human biliary metabolites of isotretinoin: identification, quantification, synthesis, and biological activity. | 1990 | Xenobiotica | pmid:2333716 |
| Kontaxakis VP et al. | Genetic vulnerability and isotretinoin-induced psychiatric adverse events. | 2010 | World J. Biol. Psychiatry | pmid:20109108 |
| Ng CH et al. | Acne, isotretinoin treatment and acute depression. | 2001 | World J. Biol. Psychiatry | pmid:12587200 |
| Atzpodien J et al. | Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid. | 1995 | World J Urol | pmid:7550391 |
| Duda-Król W et al. | [A probe using isotretinoin for treatment of poorly differentiated leukemia]. | 1996 | Wiad. Lek. | pmid:9245116 |
| Bergler-Czop B and Brzezińska-Wcisło L | [Recurrence in patients diagnosed with acne treated by isotretinoin and other methods]. | 2006 | Wiad. Lek. | pmid:16813256 |
| Kaniewski M et al. | [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid]. | 2001 | Wiad. Lek. | pmid:12182038 |
| Handkiewicz-Junak D et al. | [Use of 13-cis retinoic acid for treatment of advanced differentiated thyroid cancer]. | 2001 | Wiad. Lek. | pmid:12182039 |
| Tallab T et al. | Isotretinoin therapy: any need for laboratory assessment? | 2004 Oct-Dec | West Afr J Med | pmid:15730082 |
| Garattini E et al. | Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents. | 2007 | Vitam. Horm. | pmid:17368321 |
| Toma S and Noli C | Isotretinoin in the treatment of multiple benign pilomatrixomas in a mixed-breed dog. | 2005 | Vet. Dermatol. | pmid:16238816 |
| MashkilleÄson AL and ZaÄtseva SIu | [Roaccutan in the treatment of severe forms of acneiform eruption]. | 1989 | Vestn Dermatol Venerol | pmid:2532821 |
| Gromova SA et al. | [Roaccutan in the therapy of severe manifestations of acne vulgaris and rosacea]. | 1989 | Vestn Dermatol Venerol | pmid:2534455 |
| Page DG et al. | An alternative approach to the treatment of oral leukoplakia. | 1995 Apr-Jun | Va Dent J | pmid:9540748 |
| Healy B | Pledging for accutane. | 2005 | US News World Rep | pmid:16159042 |
| Cardamakis E et al. | Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. | 1995 | Urology | pmid:7747375 |
| Rossen MH and Roed-Petersen J | [Acne vulgaris]. | 1993 | Ugeskr. Laeg. | pmid:8460427 |
| Søderberg U and Thestrup-Pedersen K | [Fulminant acne]. | 1993 | Ugeskr. Laeg. | pmid:8328051 |
| Jemec GB | [Treatment of acne]. | 2000 | Ugeskr. Laeg. | pmid:11187138 |
| Halkier-Sørensen L and Andresen JH | [Bone changes following long-term isotretinoin (Roaccutane) treatment]. | 1989 | Ugeskr. Laeg. | pmid:2734898 |
| Jensen JB | [Isotretinoin (Roaccutan) and depression]. | 1998 | Ugeskr. Laeg. | pmid:9859736 |
| Ceviz N et al. | A case of isotretinoin embryopathy with bilateral anotia and Taussig-Bing malformation. | 2000 Jul-Sep | Turk. J. Pediatr. | pmid:11105626 |
| Kiliç E et al. | Isotretinoin (13-cis-retinoic acid)-associated premature ventricular contractions. | 2009 Jul-Aug | Turk. J. Pediatr. | pmid:19950851 |
| Tankurt E et al. | Esophageal ulcers: a possible adverse effect of isotretinoin. | 2013 | Turk J Gastroenterol | pmid:24623299 |
| Vitamin A type drug for Kaposi's sarcoma (KS). | 1995 | Treat Rev | pmid:11363023 | |
| Bellman BA et al. | Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. | 1996 | Transplantation | pmid:8560565 |
| Kiss E et al. | Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. | 2003 | Transplantation | pmid:12923432 |
| Stinson SF et al. | Atrophy induced in the tubules of the testes of Syrian hamsters by two retinoids. | 1980 | Toxicology | pmid:6938081 |
| Kameoka S et al. | A high-throughput screen for teratogens using human pluripotent stem cells. | 2014 | Toxicol. Sci. | pmid:24154490 |
| Wang K et al. | Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. | 2006 | Toxicol. Sci. | pmid:16632523 |
| Rühl R et al. | Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization. | 2001 | Toxicol. Sci. | pmid:11509747 |
| Ferguson SA et al. | Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. | 2005 | Toxicol. Sci. | pmid:16033993 |
| Macejová D et al. | Different mRNA expression profiling of nuclear retinoid, thyroid, estrogen and PPARgamma receptors, their coregulators and selected genes in rat liver and spleen in response to short-term in vivo administration of 13-cis retinoic acid. | 2009 | Toxicol. Lett. | pmid:19041696 |
| Ratajewski M et al. | Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | 2015 | Toxicol. Lett. | pmid:25455453 |
| Willhite CC et al. | Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223. | 2000 | Toxicol. Appl. Pharmacol. | pmid:10764630 |
| Collins MD et al. | Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats. | 1994 | Toxicol. Appl. Pharmacol. | pmid:8048045 |
| Tzimas G et al. | Developmental stage-associated differences in the transplacental distribution of 13-cis- and all-trans-retinoic acid as well as their glucuronides in rats and mice. | 1995 | Toxicol. Appl. Pharmacol. | pmid:7597714 |
| Eckhoff C and Willhite CC | Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters. | 1997 | Toxicol. Appl. Pharmacol. | pmid:9299599 |
| Eckhoff C et al. | Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits. | 1994 | Toxicol. Appl. Pharmacol. | pmid:8128493 |
| Silva FS et al. | The in vitro and in vivo genotoxicity of isotretinoin assessed by cytokinesis blocked micronucleus assay and comet assay. | 2013 | Toxicol In Vitro | pmid:23318729 |
| Rødland O and Helland S | [Hypertrophic granulation tissue as a complication to isotretinoin treatment]. | 1991 | Tidsskr. Nor. Laegeforen. | pmid:1835182 |